Xin-He Lai

Title: Innovations of Inventor Xin-He Lai

Introduction

Xin-He Lai is an accomplished inventor based in Portland, OR (US). He has made significant contributions to the field of microbiology, particularly in the development of vaccines and treatments for infectious diseases. His work focuses on the bacterial pathogen Francisella, which causes tularemia, a serious disease affecting both humans and animals.

Latest Patents

Xin-He Lai holds a patent for "Attenuated Francisella and Methods of Use." This patent addresses the need for a vaccine against tularemia, a widespread and life-threatening disease for which no approved vaccine currently exists. The patent details the development of attenuated mutants with functional deletions in specific genes, including dsbB, FTT0742, pdpB, fumA, and carB. Additionally, it provides immunogenic compositions that incorporate these attenuated bacteria and outlines methods for treatment using these mutants. Xin-He Lai has 1 patent to his name.

Career Highlights

Xin-He Lai is affiliated with Oregon Health & Science University, where he conducts research and collaborates with other scientists. His work has been instrumental in advancing the understanding of tularemia and developing potential therapeutic solutions.

Collaborations

Xin-He Lai has worked alongside notable colleagues, including Rebecca Tempel and Fred L. Heffron. Their collaborative efforts contribute to the ongoing research and development in the field of infectious diseases.

Conclusion

In summary, Xin-He Lai is a dedicated inventor whose work on attenuated Francisella has the potential to impact public health significantly. His contributions to vaccine development are crucial in the fight against tularemia.